Arkolith/Insider Trading/PVLA/Form 4

Goin Kathleen

Chief Operating OfficerPALVELLA THERAPEUTICS, INC. (PVLA) · full profile →Form 4 · filed May 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$476K
Net Open-Market Flow
-$476K
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2026Option exercise(M)2K$7.14$15K2K
May 20, 2026Option exercise(M)2K$9.08$20K4K
May 20, 2026Sell(S)3K$110.35$371K939
May 20, 2026Sell(S)891$111.30$99K48
May 20, 2026Sell(S)48$111.89$5K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 20, 2026Option exercise(M)2K—$011K
May 20, 2026Option exercise(M)2K—$011K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-065692) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML